Clinical validity of blood and urinary desmosine as biomarkers for chronic obstructive pulmonary disease

J. Huang, R. Chaudhuri, A. Barton, J. Brady, C. Grierson, O. Albarbarawi, P. Rauchhaus, C. Weir, M. Messow, C. McSharry, G. Feuerstein, S. Mukhopadyhay, C. Palmer, D. Miller, N. Thomson (Dundee, Glasgow, United Kingdom; Collegeville, United States Of America)

Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Session: Monitoring exacerbations of airway diseases
Session type: Thematic Poster Session
Number: 903
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Huang, R. Chaudhuri, A. Barton, J. Brady, C. Grierson, O. Albarbarawi, P. Rauchhaus, C. Weir, M. Messow, C. McSharry, G. Feuerstein, S. Mukhopadyhay, C. Palmer, D. Miller, N. Thomson (Dundee, Glasgow, United Kingdom; Collegeville, United States Of America). Clinical validity of blood and urinary desmosine as biomarkers for chronic obstructive pulmonary disease. Eur Respir J 2011; 38: Suppl. 55, 903

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease
Source: ERJ Open Res, 7 (3) 00068-2021; 10.1183/23120541.00068-2021
Year: 2021



Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020


Clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012


The usefullness of the chronic obstructive pulmonary disease assessment test
Source: Annual Congress 2011 - Clinical parameters in airway diseases
Year: 2011

Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012


Increased urinary l-histidine in patients with asthma–chronic obstructive pulmonary disease overlap
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018



The usefulness of pedometry in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance
Year: 2012


Association between serum YKL-40 and chronic obstructive pulmonary disease
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Blood eosinophilia in chronic obstructive pulmonary disease: impact on exacerbations risk and severity
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


Validity of serum surfactant protein D as a lung-specific biomarker in monitoring asthma, chronic obstructive pulmonary disease and chronic bronchitis in Lebanese patients: Preliminary results
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012


Correlation between the pulmonary hemodynamic and spirometric parameters in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 25s
Year: 2002

Prevalence and clinical characteristics of blood eosinophilia in patients with acute exacerbation of chronic obstructive pulmonary disease in China
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 258s
Year: 2002

Extracellular ATP as a biomarker of severity of chronic obstructive pulmonary disease
Source: International Congress 2019 – Injury and repair: less is more
Year: 2019




Association of inflammatory biomarkers with comorbidity in chronic obstructive pulmonary disease – results from the COSYCONET cohort
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017

Safety and effectiveness of sputum induction in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 67s
Year: 2001

Clinical and investigational profiles of elevated pulmonary artery pressures in patients with stable chronic obstructive pulmonary diseases
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019

Relationship between proteases/anti-proteases system in induced sputum and spirometry testing in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 634s
Year: 2006

Development of the chronic obstructive pulmonary disease assessment questionnaire
Source: Annual Congress 2008 - Social determinants and psychological issues in primary care respiratory diseases
Year: 2008